Related Experiment Video
Updated: Aug 10, 2026

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and
Hiroshi Nakamura1, Shahid S Siddiqui, Xiang Shen
1Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, 60612, USA.
Purpose:
Transforming growth factor-beta(TGF-beta) is an important mediator of wound healing responses. In the eye, TGF-beta activity has been implicated in causing corneal haze after laser surgery and subconjunctival scarring following glaucoma surgery. The purpose of the study was to determine whether small interference RNAs (siRNAs) targeting the type II receptor of TGF-beta (TbetaRII) could be used to suppress the TGF-beta action.
Methods:
TbetaRII specific siRNAs designed from the human gene sequence were transfected into cultured human corneal fibroblasts. The protein and transcript levels of the receptor were determined by immunofluorescence, western blotting, and real time PCR. Immunofluorescence and immunoblotting were carried out to examine fibronectin assembly. A wound closure assay was used to assess cell migration in in vitro fibroblast cultures. In addition, the in vivo effects of TbetaRII siRNA were evaluated in a mouse model of ocular inflammation and fibrosis generated by subconjunctival injection of phosphate buffered saline and latex beads. Mouse TbetaRII siRNA was introduced into experimental eyes. Cellularity on tissue sections was evaluated after staining with hematoxylin and eosin. Collagen deposition was visualized by picrosirius red staining.
Results:
TbetaRII siRNAs abrogated the receptor transcript and protein expression in cultured corneal fibroblasts. The gene knockdown inhibited fibronectin assembly and retarded cell migration. In the mouse model, introduction of TbetaRII specific siRNA significantly reduced the inflammatory response and matrix deposition.
Conclusions:
TbetaRII specific siRNAs were efficacious both in vitro and in vivo in knocking down the TGF-beta action. A direct application of siRNA into eyes to downregulate TbetaRII expression may provide a novel therapy for preventing ocular inflammation and scarring.
Insights
Small interference RNAs (siRNAs) targeting the TGF-beta type II receptor (TbetaRII) effectively reduced TGF-beta
Area of Science:
- Ophthalmology
- Molecular Biology
- Wound Healing Research
Background:
- Transforming growth factor-beta (TGF-beta) is a key mediator in wound healing.
- Elevated TGF-beta activity is linked to ocular complications like corneal haze and scarring.
- Targeting TGF-beta signaling is crucial for managing ocular inflammatory and fibrotic conditions.
Purpose of the Study:
- To investigate the efficacy of small interference RNAs (siRNAs) against the TGF-beta type II receptor (TbetaRII).
- To determine if TbetaRII-specific siRNAs can suppress TGF-beta mediated actions in ocular tissues.
Main Methods:
- Transfection of TbetaRII specific siRNAs into human corneal fibroblasts.
- Assessment of receptor expression, fibronectin assembly, and cell migration in vitro.
- Evaluation of siRNA effects on ocular inflammation and fibrosis in a mouse model.
Main Results:
- TbetaRII siRNAs significantly reduced TbetaRII transcript and protein levels.
- siRNA treatment inhibited fibronectin assembly and cell migration in vitro.
- In vivo, TbetaRII siRNA suppressed ocular inflammation and matrix deposition.
Conclusions:
- TbetaRII specific siRNAs are effective in inhibiting TGF-beta action both in vitro and in vivo.
- Ocular application of TbetaRII siRNA may offer a new therapeutic strategy for preventing eye inflammation and scarring.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

